Advances in Takayasu arteritis: An Asia Pacific perspective

Debashish Danda; Prathyusha Manikuppam; Xinping Tian; Masayoshi Harigai

doi:10.3389/fmed.2022.952972

Advances in Takayasu arteritis: An Asia Pacific perspective

Front Med (Lausanne). 2022 Aug 15:9:952972. doi: 10.3389/fmed.2022.952972. eCollection 2022.

Authors

Debashish Danda¹, Prathyusha Manikuppam¹, Xinping Tian², Masayoshi Harigai³

Affiliations

¹ Department of Clinical Immunology and Rheumatology, Christian Medical College and Hospital, Vellore, India.
² Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College Hospital (PUMCH), Beijing, China.
³ Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.

Abstract

Takayasu Arteritis (TA) is a rare form of chronic granulomatous large vessel vasculitis that is more common in Asia compared to other parts of the world. There have been several developments in the field of Takayasu arteritis in relation to genetics, classification, clinical features, imaging, disease activity assessment and management and much of these works have been done in the Asia Pacific region. We will be discussing selected few in the current review.

Keywords: HLA B52; ITAS; PET-VAS; PET/MRI; Takayasu arteritis; biologicals; granulomatous vasculitis.

Publication types

Review